TARGET AUDIENCE

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants will be better able to do the following:

1. Understand the metastatic melanoma science, including patient screening, diagnostic criteria, 
and the mechanism of action of oncolytic viral therapeutics. 

2. Analyze evidence based medicine for combination therapies that apply oncolytic viral 
therapeutics to the treatment of metastatic melanoma.
3. Incorporate communication strategies and patient education into individualized treatment plans 
to improve outcomes and the overall quality of life in patients with metastatic melanoma.
    

FACULTY

	Michael Postow, MD (Course Chair) Medical Oncologist Melanoma and Immunotherapeutics Service Memorial Sloan Kettering Cancer Center New York, New York
	Charlotte Ariyan, MD, PhD Surgical Oncologist Memorial Sloan Kettering Cancer Center New York, New York
	Francesca Mistretta, BSN, RN, CMSRN Memorial Sloan Kettering Cancer Center New York, New York

Disclosure of Conflicts of Interest

It is the policy of the Elsevier Office of Continuing Medical Education that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity. 

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Financial Support

This activity has been supported by an independent educational grant from Amgen Inc.

Provider Information

Co-provided by the Elsevier Office of Continuing Medical Education and AcademicCME.

CME Credit (Physicians)

The Elsevier Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.

The Elsevier Office of Continuing Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME INQUIRIES/SPECIAL NEEDS

For all CME inquiries or special needs, please contact elsevierCME@elsevier.com.

Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Elsevier Office of Continuing Medical Education, AcademicCME and Amgen Inc. do not recommend the use of any agent outside of the labeled indications.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.